CG Oncology Announces $105 Million Oversubscribed Crossover Financing to Support Continued Advancement of Clinical-Stage Bladder Cancer Pipeline

CG Oncology

related news
NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy

NASDAQ

July 14 2026
Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats up

Reuters

April 18 2026

Get In Touch

Contact Us